Akoya Biosciences
Akoya, Singapore Consortium Collaborate to ID Markers of Response to Checkpoint Inhibitor Therapy
The project will use Akoya's PhenoCode Discovery IO60 Panel to look at matched pairs of immuno-oncology exceptional responders and hyper-progressors.
Investment firm Kent Lake said the securities deal, which is linked to the firm's planned acquisition of Akoya, is "backdoor financing" and "highly unfavorable to Quanterix shareholders."
Major Quanterix Investor Opposes $30M Akoya Securities Purchase Agreement
Investment firm Kent Lake said the deal, which is linked to the firm's planned acquisition of Akoya, is "backdoor financing" and "highly unfavorable to Quanterix shareholders."
Akoya Biosciences Fourth Quarter Revenues Down 19 Percent
Pending acquisition by Quanterix, which was announced in January, the spatial biology firm did not host an earnings call or issue forward guidance for 2025.
In Brief This Week: Guardant Health, Genetic Signatures, Mainz Biomed, Devyser, Akoya, More
News items for the week of Jan. 27, 2025.
Jan 10, 2025
Quanterix to Acquire Akoya Biosciences
Nov 8, 2023